3 Minutes To Boost Your Earnings: 3 Stocks With Over 3% Dividend Yields In Health Care Sector From Wall Street's Most Accurate Analysts
Portfolio Pulse from Avi Kapoor
The article highlights three health care sector stocks with over 3% dividend yields, as rated by Wall Street's most accurate analysts. Organon & Co. (OGN) has a 7.93% yield with mixed ratings and a price target cut. Viatris Inc. (VTRS) offers a 4.48% yield, with one analyst upgrading the price target and another downgrading the stock. CVS Health Corporation (CVS) has a 3.37% yield, with both analysts maintaining positive ratings but reducing price targets. Recent news for each company is also provided, which could influence their stock performance.
December 27, 2023 | 12:42 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Organon & Co. has a high dividend yield of 7.93% with a recent price target cut by analysts. The company is now the sole distributor for Eli Lilly's migraine medicines in Europe.
While the high dividend yield is attractive, the price target cut by analysts could indicate concerns about the company's future performance. However, the new distribution deal with Eli Lilly could offset some negative sentiment.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Viatris Inc. has a dividend yield of 4.48%. Analysts have mixed opinions, with one raising the price target and another downgrading the stock. The company announced new executive appointments.
The mixed analyst ratings and executive changes could lead to uncertainty in the short term, balancing the potential impact on the stock price.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 80
POSITIVE IMPACT
CVS Health Corporation has a 3.37% dividend yield, with analysts maintaining positive ratings despite reducing price targets. The company confirmed FY23 guidance and announced a quarterly dividend.
The confirmation of FY23 guidance and the announcement of a quarterly dividend are positive signs for investors, which could lead to a short-term positive impact on the stock price, despite the reduced price targets.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 90